Benjamin Looker - Jan 27, 2022 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
General Counsel
Signature
/s/ Richard B. Bartram, by power of attorney
Stock symbol
ESPR
Transactions as of
Jan 27, 2022
Transactions value $
$0
Form type
4
Date filed
1/28/2022, 04:07 PM
Previous filing
Jan 4, 2022
Next filing
Jun 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Award $0 +70.8K $0.00 70.8K Jan 27, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ESPR Stock Option (right to buy) Award $0 +100K $0.00 100K Jan 27, 2022 Common Stock 100K $3.65 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Such award will vest over a four (4) year period as follows: 25% shall vest on the one year anniversary of January 15, 2022 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter, subject to continued service.
F2 Such options will vest over a four (4) year period as follows: 25% shall vest on the one year anniversary of January 15, 2022 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter, subject to continued service.